MindWalk Holdings (HYFT) Net Margin Growth (3y) (2023 - 2026)
Powered by 
Analysis
MindWalk Holdings (HYFT) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | -374.00 |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | -44.00 |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | 6,620.00 |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | -13,815.00 |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 7,793.00 |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 9,934.00 |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | -5,319.00 |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 31,387.00 |
| 10 | MindWalk Holdings | 61.23 Mn | 52.95 Mn | 1.82 Mn | 5,704.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Apr 30, 2026 | 5,704.00 |
| Jan 31, 2026 | -223.00 |
| Oct 31, 2025 | 7,570.00 |
| Jul 31, 2025 | 25,018.00 |
| Apr 30, 2025 | -16,873.00 |
| Jan 31, 2025 | -91,213.00 |
| Oct 31, 2024 | -3,892.00 |
| Jul 31, 2024 | 7,966.00 |
| Apr 30, 2024 | 39,059.00 |
| Jan 31, 2024 | -3,519.00 |
| Oct 31, 2023 | -4.88 Mn |